Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
Incyte Launches Vitiligo Innovators Program; Announces 2023 IIA Vitiligo Winners - The Dermatology Digest
Search

Incyte Launches Vitiligo Innovators Program; Announces 2023 IIA Vitiligo Winners

Incyte is launching the Vitiligo Innovators Program (VIP), which honors patients, caregivers, advocates, researchers, medical students, residents, and healthcare providers who have made contributions to the vitiligo community.

In related news, UMass Chan Medical School, Department of Dermatology, and Litty Ligo Vitiligo Community Network received the 2023 Incyte Ingenuity Awards (IIA) in vitiligo.

Individual nominations for VIP and applications for the 2024 IIA in Vitiligo are now open until October 31, 2024. To learn more, visit vitiligoinnovatorsprogram.com or incyteingenuityawards.com/vitiligo.

UMass Chan Medical School, Department of Dermatology received the up to $100,000 award to implement its project, Removing Educational Equity Barriers for Individuals with Vitiligo, which sets out to identify the gaps in public education in vitiligo, particularly for children and those who are non-native English language speakers through public educational materials.

The Litty Ligo Vitiligo Community Network received up to $35,000 award to implement Beautiful Both Ways: A Celebration of You, aimed at acknowledging and providing support for commonly reported obstacles by the vitiligo community, such as maintaining a healthy body image, managing self-esteem, and understanding mental health through an in-person community event.

“By supporting these impactful initiatives and recognizing individuals who have made significant strides in their unwavering commitment to this community, we believe we can truly make a difference for those living with this condition,” says Matteo Trotta, Executive Vice President and General Manager of U.S. Dermatology at Incyte in a news release.